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Chlamydia are Gram negative bacterial pathogens responsible for disease in humans
and economically important domesticated animals. As obligate intracellular bacteria, they
must gain entry into a host cell where they propagate within a parasitophorous organelle
that serves as an interactive interface between the bacterium and the host. Nutrient
acquisition, growth, and evasion of host defense mechanisms occur from this location.
In addition to these cellular and bacterial dynamics, Chlamydia differentiate between
two morphologically distinct forms, the elementary body and reticulate body, that are
optimized for either extracellular or intracellular survival, respectively. The mechanisms
regulating and mediating these diverse physiological events remain largely unknown.
Reversible phosphorylation, including classical two-component signaling systems,
partner switching mechanisms, and the more recently appreciated bacterial Ser/Thr/Tyr
kinases and phosphatases, has gained increasing attention for its role in regulating
important physiological processes in bacteria including metabolism, development, and
virulence. Phosphorylation modulates these events via rapid and reversible modification
of protein substrates leading to changes in enzyme activity, protein oligomerization, cell
signaling, and protein localization. The characterization of several conserved chlamydial
protein kinases and phosphatases along with phosphoproteome analysis suggest that
Chlamydia are capable of global and growth stage-specific protein phosphorylation. This
mini review will highlight the current knowledge of protein phosphorylation in Chlamydia
and its potential role in chlamydial physiology and, consequently, virulence. Comparisons
with other minimal genome intracellular bacterial pathogens also will be addressed with
the aim of illustrating the importance of this understudied regulatory mechanism on
pathogenesis and the principle questions that remain unanswered.
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INTRODUCTION
Chlamydia are obligate intracellular bacteria that are responsible for diseases in humans and
animals creating a significant burden on global health and national economies (Horn, 2008;
World Health Organization, 2016a,b). These pathogens undergo a biphasic developmental cycle,
transitioning between twomorphologically and functionally distinct forms known as the infectious
elementary body (EB) and the replicative reticulate body (RB) (Abdelrahman and Belland, 2005).
Infection begins with EB attachment to a mucosal epithelial cell. Upon contact, the type 3
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secretion system (T3SS) secretes prepackaged effector proteins
to induce EB internalization into a parasitophorous organelle
termed the inclusion (Moore and Ouellette, 2014). Following
entry, Chlamydia exploits host cell trafficking machinery to exit
the endocytic pathway and migrate to a perinuclear position
where the inclusion can interact with the exocytic pathway
(Hackstadt, 2000). The EBs differentiate into metabolically active
RBs that grow and divide via a polarized budding-like process
(Abdelrahman et al., 2016). Both bacterial and host proteins
are incorporated into the growing inclusion, and numerous
bacterial proteins are secreted into the inclusion lumen and
host cell cytoplasm leading to host protein recruitment,
nutrient acquisition, maintenance of anti-apoptotic pathways,
and modulation of innate immune mechanisms (Bastidas et al.,
2013). RBs eventually differentiate back into EBs and exit the
host cell via lysis or inclusion extrusion approximately 48–72
h post-infection (Hybiske and Stephens, 2007). Exposure to
stress, including antibiotics, IFNγ, or iron deprivation during
intracellular growth, can induce a reversible persistent state
characterized by formation of viable, non-dividing, aberrant
RBs (Wyrick, 2010). Persistent Chlamydia undergo differential
gene expression depending on the persistence-inducing stimuli
(Belland et al., 2003a; Goellner et al., 2006; Mäurer et al., 2007).
Despite the essentiality of development to infection,
making it an ideal target for therapeutics, relatively little
is known about the signals and mechanisms regulating
this process. Chlamydia possess three sigma factors,
σ
66, σ28, and σ54 (encoded by rpoD, rpsD, and rpoN,
respectively), and exhibit developmental stage-specific gene
expression patterns corresponding to an early, middle,
and late stage of infection (Stephens et al., 1998; Shaw
et al., 2000; Belland et al., 2003b). We hypothesize that
post-translational regulatory mechanisms help regulate and
mediate chlamydial development in addition to the more
classical transcriptional regulators that have been described for
Chlamydia.
Global protein phosphorylation in prokaryotes has more
recently been appreciated for its role in regulating important
biological processes through reversible modification of protein
function by protein kinases and phosphatases (Mijakovic
and Macek, 2012). Protein phosphorylation controls a broad
range of processes such as development, virulence, and
adaptive responses through dynamic control of enzyme
activity, protein localization, signal transduction, and protein
oligomerization (Pereira et al., 2011; Grangeasse et al., 2012).
The reduced genomes of Chlamydia encode a limited, but
we hypothesize important, arsenal of phosphorylation-related
proteins. This review examines the current knowledge of protein
phosphorylation in chlamydial physiology and development,
summarized in Figure 1, and highlights future avenues for
exploration.
PHOSPHOPROTEOME
Phosphoproteomic analysis of numerous bacteria has established
that while less prevalent than protein phosphorylation in
eukaryotes, which can phosphorylate greater than 50% of their
proteome, protein phosphorylation is an integral feature of
bacterial physiology and pathogenesis (Jers et al., 2008; Olsen
et al., 2010). Phosphoproteomic analysis has been performed
with the EB and RB forms of Chlamydia caviae, a Guinea
pig pathogen with 80% of its genes having homologs in
the human pathogens Chlamydia trachomatis and Chlamydia
pneumoniae (Read et al., 2003). The C. caviae phosphoproteome
contains at least 42 proteins (4% of the proteome) of which
41 have homologs in all sequenced Chlamydia (Fisher et al.,
2015). Consistent with the promiscuous nature of Hank’s type
kinases (Pereira et al., 2011), the number of phosphorylated
proteins exceeds the number of known functional chlamydial
protein kinases (two). The phosphoproteins are differentially
allocated between EB (74%) and RB (19%) forms with
only three proteins shared between the two developmental
forms. The EB phosphoproteome is enriched for proteins
involved in central and secondary metabolism along with
hypothetical and virulence proteins. In contrast, the RB
phosphoproteome is primarily associated with protein synthesis
and folding.
Among the phosphoproteins that were identified in EBs, the
largest class consisted of proteins involved in energy production
(23%). While EBs are metabolically inactive, proteome studies
and axenic culturing conditions indicate that EBs contain, and
can likely activate, the majority of enzymes involved in central
and secondary metabolism suggesting that they are primed
for metabolism upon entry into the host cell (Omsland et al.,
2012). The majority of EB-phosphorylated metabolic proteins
were not phosphorylated in RBs supporting the hypothesis
that phosphorylation acts to rapidly modulate the activity
of metabolic enzymes alleviating the need for transcriptional
and translational machinery during immediate-early infection.
In addition, the T3SS structural proteins CdsN and CdsD
(phosphorylated in vitro, Johnson and Mahony, 2007) were
phosphorylated in EBs, but not RBs. One hypothesis is that the
T3SS may be held in an off state until contact is made with the
host cell, in part, by phosphorylation.
The published chlamydial phosphoproteome is likely
underrepresented as phosphoproteomes are dynamic and
change over time and under different conditions. For example,
we speculate that the phosphoproteome would vary between
early, middle, and late stage growth and during persistence
to fulfill the physiological needs of each developmental stage.
While the asynchronous nature of the RB to EB transition,
sensitivity of detection, and lability of phospho-modifications
represent challenges for phosphoproteome mapping, newer
mass spectrometry methods overcome many of these limitations
and could be applied to multiple chlamydial species to obtain
temporal phosphoproteome maps capturing phospho-site
data (limited phospho-site information was obtained from the
C. caviae study). To date, the phosphoproteomes of other obligate
intracellular pathogens have not been examined. Coxiella, which
encode multiple protein kinases and phosphatases (Table 1)
and undergo developmental alterations, would appear to be the
ideal candidate for phosphoproteome analysis (Minnick and
Raghavan, 2012).
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FIGURE 1 | Overview of Protein Phosphorylation in Chlamydia. (A) Individual proteins: Chlamydia spp. encode two validated Hank’s type kinases, Pkn1 and
PknD. Pkn1 is predicted to reside in the cytoplasm and may interact with IncG, an inclusion membrane protein. PknD is an integral membrane protein that most likely
binds to an unidentified ligand and interacts with CdsD, a component of the T3SS apparatus. CdsN, the T3SS ATPase, may also be modified by phosphorylation.
Both Pkn1 and PknD have been shown to undergo autophosphorylation and interact with each other. Pkn5 is predicted to be a pseudokinase that is secreted via the
T3SS. Chlamydia also encode three protein Ser/Thr phosphatases. Cpp1 is a broad specificity PP2C that may function intracellularly in concert with Pkn1 and PknD.
The chlamydial PSM consists of two sensor phosphatases (RsbU and CT_589), two anti-anti-sigma factors (RsbV1 and RsbV2), an anti-sigma factor (RsbW), and
σ
66. CT_589 is a paralog of RsbU that lacks a functional phosphatase domain and is proposed to interact with RsbU and/or to sequester RsbV1/2. CtcB and CtcC
comprise the only complete TCSS in Chlamydia spp. The HK, CtcB, undergoes autophosphorylation on a conserved histidine residue, which is transferred to the RR,
CtcC. While CtcC lacks a DNA binding domain, it is able to undergo oligomerization in the absence of DNA, which is then thought to interact with σ54 to promote
(Continued)
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FIGURE 1 | Continued
transcription. ChxR is an atypical response regulator, lacking a cognate HK and the conserved phospho-receiving aspartate residue. ChxR undergoes dimerization,
binds DNA, and likely serves as a transcriptional activator. McsB, upon activation by McsA, mediates protein homeostasis by phosphorylating proteins and targeting
them for degradation by the Clp protease. TarP, TepP, IncA, and IncG are T3SS effector proteins that are phosphorylated by host kinases and are involved in cell
invasion and inclusion development. Protein kinases and the pseudokinase Pkn5 are colored in red. Proteins with phosphatase activity or phosphatase-like domains
(CT_589) are colored in purple. Known interactions are represented by solid lines and hypothetical interactions are shown by dashed lines. (B) Global patterns: The EB
phosphoproteome is widely distributed and extensive compared to RBs with the largest class of proteins involved in energy production. In RBs, the majority of
phosphoproteins are involved in protein synthesis and folding. In this model, proteins involved in metabolism and virulence are phosphorylated to prime EBs for
infection and energy production. Following entry into the host cell, reversible phosphorylation rapidly reorganizes the phosphoproteome to prepare for EB to RB
differentiation. During RB development, proteins are further modulated to optimize metabolism, protein synthesis/folding, and other unidentified functions for growth
and replication. Upon exposure to persistence inducing stimuli, Chlamydia enter a persistent state (PS) associated with a global transcriptional response that may
ultimately lead to altered proteomic profiles, which in turn impact the phosphoproteomic landscape. Upon removal of the persistence inducing stimuli, the
phosphoproteome would shift back to the RB phosphoproteome, which likely varies throughout development and converges on the EB phosphoproteome during RB
to EB differentiation. Bars represent the relative number of proteins in EB (orange) and RB (purple) phosphoproteomes within each functional category. Solid arrows
indicate the flow of phosphorylation and thickness is proportional to the abundance of phosphoproteins.
TABLE 1 | Summary of phosphoproteins in pathogenic obligate intracellular bacteria.
C. trachomatis
D/UW-3/CXa
Coxiella burnetii
RSA 493
Rickettsia rickettsii
str. Hlp#2
Anaplasma
phagocytophilum
str. HZ
Ehrlichia chaffeensis
str. Arkansas
Protein kinase CT_145
CT_301
CT_673
CBU_0175
CBU_1168b
CBU_1379b
NA NA NA
Protein phosphatase CT_259 CBU_0488
CBUA0032c
NA NA NA
Rsb—partner
switching
mechanism
CT_424
CT_549
CT_588
CT_589
CT_765
NAd NA NA NA
Histidine kinase CT_467 CBU_0789
CBU_1761
CBU_2005e
RPK_RS00325
RPK_RS01565
RPK_RS02040
RPK_RS02045
RPK_RS04660
APH_RS00610
APH_RS02470f
APH_RS03745
ECH_RS01200
ECH_RS03125f
ECH_RS03640
Response regulator CT_468
CT_630
CBU_0712
CBU_0760
RPK_RS00525
RPK_RS01630
RPK_RS02880
APH_RS02370
APH_RS04365
ECH_RS03205
ECH_RS04140
Arginine kinase CT_675 NA NA NA NA
aLocus tags of predicted genes in each category are based on genome annotation. Chlamydia trachomatis D/UW-3/CX, NC_000117.1; Coxiella burnetii RSA 493, NC_002971.3
(chromosome) and NC_004704.1 (plasmid); Rickettsia rickettsii str. Hlp#2, NC_016915.1; Anaplasma phagocytophilum str. HZ, NC_007797.1; and Ehrlichia chaffeensis str. Arkansas,
NC_007799.1.
bFrameshifted ORF.
cPlasmid-encoded.
dNot Annotated.
eHistidine Kinase-like.
fHybrid Sensor Histidine Kinase/Response Regulator.
PROTEIN KINASES AND PHOSPHATASES
First discovered in eukaryotes, reversible protein
phosphorylation on Ser/Thr/Tyr residues has gained a wider
appreciation for its diverse role in regulating bacterial physiology
(Deutscher and Saier, 2005). Ser/Thr phosphorylation and Tyr
phosphorylation are typically mediated by Hank’s type kinases
and bacterial tyrosine kinases (BY), respectively (Cousin et al.,
2013). These enzymes use ATP as the phospho-donor and are
known to be promiscuous regarding their protein substrate
preference (Pereira et al., 2011). P-Ser/Thr/Tyr residues, unlike
P-Asp and P-His residues found in two-component signaling
systems, form more stable ester linkages requiring dedicated
protein phosphatases working in conjunction with their cognate
kinase (Klumpp and Krieglstein, 2002). Protein phosphatases
are divided into two superfamilies: protein Ser/Thr phosphatases
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(PSPs), which are subdivided into phosphoprotein phosphatases
(PPP) and protein phosphatases metal-dependent (PPM), and
protein tyrosine phosphatases (PTPs) (Shi, 2009). BY kinases
and PTPs are strongly associated with virulence (Whitmore and
Lamont, 2012). In addition, an arginine kinase, McsB, plays a
role in targeting proteins for degradation by the Clp protease
system in some bacteria (Trentini et al., 2016).
All sequenced Chlamydia encode two validated Hank’s type
kinases, Pkn1 (cytoplasmic) and PknD (inner membrane),
and a putative pseudokinase, Pkn5 (T3SS effector) (Verma
and Maurelli, 2003; Johnson and Mahony, 2007), along with
a putative arginine kinase, McsB. Pkn1 and PknD from C.
trachomatis have been shown to autophosphorylate on Ser/Thr
residues and to interact with each other, suggesting cross-
regulation (Verma and Maurelli, 2003). In vitro approaches
identified the inclusion membrane protein IncG as a Pkn1
substrate for C. trachomatis (Verma and Maurelli, 2003) and
the T3SS structural protein CdsD as a PknD substrate for C.
pneumoniae (Johnson and Mahony, 2007). While Pkn1 can
phosphorylate IncG in vitro, IncG is likely phosphorylated by a
host kinase in vivo, similar to IncA (Rockey et al., 1997; Scidmore
and Hackstadt, 2001). Pkn1, PknD, and Pkn5 are transcribed
throughout development and the proteins have been detected in
the RB form using mass spectrometry or Western blot (Belland
et al., 2003b; Verma and Maurelli, 2003; Albrecht et al., 2010;
Saka et al., 2011; Skipp et al., 2016). Interestingly, two forms of
PknD have been detected indicating that it may function in its full
length membrane-bound form and as a truncated, cytoplasmic
form containing the kinase domain (Verma and Maurelli, 2003).
While Pkn1 and PknD from C. trachomatis were found
to phosphorylate Ser/Thr residues, but not Tyr (Verma and
Maurelli, 2003), PknD from C. pneumoniae was shown to
autophosphorylate on Thr/Tyr residues and to phosphorylate
Ser/Tyr residues on CdsD (Johnson and Mahony, 2007). Tyr-
phosphorylation by a Hank’s type kinase is unusual and suggests
a relaxed substrate specificity for the C. pneumoniae PknD.
Sequence analysis and in vitro studies suggest that Pkn5 is a
pseudokinase as it lacks conserved catalytic residues (Verma and
Maurelli, 2003). Pkn5 is encoded in an operon containing T3SS
genes and has been shown to serve as a T3SS substrate in a
Salmonella surrogate T3SS assay (Ho and Starnbach, 2005). In
addition, Pkn5 from C. pneumoniae localizes to the inclusion
membrane (Herrmann et al., 2006) further supporting its role as
an effector protein.
In contrast to most other bacteria, the protein kinases,
phosphatases, and substrates do not appear to be encoded
within operons in Chlamydia complicating the mapping of
the phosphoprotein network. We recently characterized a
protein phosphatase from C. trachomatis, Cpp1, which we
hypothesize to partner with Pkn1 and PknD completing a
reversible phosphoprotein network (Claywell and Fisher, 2016).
All sequenced Chlamydia spp. encode Cpp1, which is a member
of the PPM family of phosphatases. Additional PPM proteins in
Chlamydia include RsbU and CT_589, a paralog of RsbU, which
are assigned to the partner switching mechanism (Hua et al.,
2006). Cpp1 is a member of the protein phosphatase type 2C
(PP2C) subfamily of PPMs and is able to dephosphorylate P-Ser,
P-Thr, and P-Tyr. Dephosphorylation of P-Tyr is not a common
feature of PP2Cs. The broad substrate preference of Cpp1 in
conjunction with the unique ability of the C. pneumoniae PknD
to phosphorylate Tyr residues supports the presence of P-Tyr in
Chlamydia despite the absence of PTP and BY kinases, which are
present in the larger genomes of chlamydial ancestors (Collingro
et al., 2011). Similar broadening of substrate specificity leading to
loss of genes encoding proteins with narrow substrate preferences
has also been seen for the chlamydial nucleotide transporters
(Fisher et al., 2013). Studies should be pursued to address whether
tyrosine phosphorylation is present in other Chlamydia or if it is
restricted to C. pneumoniae.
Numerous studies support the importance of protein
phosphorylation to chlamydial growth and virulence. A
Chlamydia psittaci strain containing a radical mutation on a
conserved Ser residue of Pkn5, which serves as a potential
phosphorylation and/or binding site for host proteins,
is attenuated for virulence in a mouse pneumonia model
(Miyairi et al., 2011), and chemically induced C. trachomatis
mutants possessing small plaque morphologies carry missense
mutations mapping back to the kinases and Cpp1 (Kokes et al.,
2015). In addition, the absence of nonsense mutations for
PknD/Pkn1/Cpp1 indicates that these enzymes may be essential
for chlamydial growth (Kokes et al., 2015). Finally, inhibition
of PknD (Johnson et al., 2009) significantly reduces growth of
C. pneumoniae further suggesting that protein phosphorylation
is integral to chlamydial physiology and that these enzymes
could be therapeutic targets.
REGULATION OF TRANSCRIPTION
THROUGH THE PARTNER SWITCHING
MECHANISM AND TWO-COMPONENT
SIGNALING SYSTEMS
Adaptive responses are frequently mediated by differential
gene expression in response to external stimuli. Bacteria often
perform these tasks using two-component signaling systems,
which are found in Chlamydia and other obligate intracellular
bacteria (Table 1), and less frequently via partner switching
mechanisms (PSMs). Chlamydia encode a regulator of sigma
B (Rsb)-type PSM, which has been extensively studied in
Bacillus (Wise and Price, 1995). This regulatory mechanism
controls the availability of sigma factors in Bacillus by
a series of protein-protein interactions that are themselves
regulated by phosphorylation (Hecker and Völker, 2001).
In the Bacillus PSM module, the anti-sigma factor RsbW
phosphorylates the anti-anti-sigma factor RsbV, freeing itself
to sequester the target sigma factor. In the presence of a
signal, the sensor phosphatase RsbU dephosphorylates RsbV,
leading to binding of RsbV to RsbW and release of the
sigma factor. The free ratio of the sigma factor is dependent
upon levels of PSM proteins and the activity of the sensor
phosphatase.
In Chlamydia, the PSM includes one validated (RsbU) and
one putative sensor phosphatase (CT_589 which lacks critical
PP2C residues), two anti-anti-sigma factors, RsbV1 and RsbV2,
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and an anti-sigma factor, RsbW (Douglas and Hatch, 2000;
Hua et al., 2006). The chlamydial PSM appears to modulate
the availability of σ66, the major sigma factor responsible for
transcription of housekeeping genes (Thompson et al., 2015).
When RsbV1 was overexpressed in C. trachomatis, transcription
of σ66 regulated genes was upregulated and the cells exhibited
increased growth, whereas the inverse occurred when RsbW was
overexpressed or when RsbV1 was inactivated. Consistent with
the classical model, RsbW and RsbU are able to govern the
phosphorylation status of RsbV1. In contrast, RsbV2, which is
phosphorylated by RsbW (at reduced rates compared to RsbV1),
could not be dephosphorylated by RsbU. The current working
PSM model suggests that it serves as a molecular throttle on
metabolic activity and consequently growth rate. PSM mutant
strains are currently being put through normal and “stress”
conditions to further test the PSM model. Ligands controlling
the sensor phosphatases, the roles of CT_589 and RsbV2, and
whether other targets for RsbW and RsbV2 exist remain to be
explored.
Two-component signaling systems (TCSS) enable adaptive
responses to changing environmental conditions (Mitrophanov
and Groisman, 2008). Obligate intracellular bacterial pathogens,
unlike most free-living bacteria, are reliant on the host for
development and appear to encode a limited number of TCSSs. In
the classical form, TCSSs consist of the integral membrane sensor
histidine kinase (HK) and a cytoplasmic response regulator
(RR). Various signals (pH, temperature, osmolarity, etc.) lead to
autophosphorylation of the HK on a conserved histidine residue
and subsequent phospho-transfer to the receiver domain of a
cognate RR on an invariant aspartate residue. Classical RRs
oligomerize and bind to DNA through their output domains
leading to alterations in transcription.
Chlamydia spp. possess a single complete TCSS along with an
orphaned RR (Koo and Stephens, 2003; Koo et al., 2006). The
chlamydial HK and cognate RR, CtcB and CtcC, are homologous
to NtrB/AtoS and NtrC/AtoC, respectively, and are predicted
to modulate the expression of σ54 regulated genes. CtcC-type
activators promote transcription by binding DNA at enhancers,
forming oligomers, and inducing ATPase activity that converts
closed complexes to open complexes (Tucker and Sallai, 2007).
Interestingly, CtcC lacks the helix-turn-helix domain responsible
for DNA binding among σ54 activators (Koo and Stephens,
2003). Dimeric and tetrameric forms of CtcC were detected
in the absence of DNA, suggesting enhancer binding is not
necessary for σ54 RNA polymerase holoenzyme activation. While
the physiological role of CtcB/CtcC is not yet known, this system
is developmentally regulated as transcripts and protein levels
are present during late development and are speculated to play
a role in RB to EB differentiation. In addition to CtcB and
CtcC, Chlamydia also encode ChxR, a response regulator that is
homologous to the OmpR subfamily, but is atypical in that the
receiver domain lacks the invariant Asp residue (Koo et al., 2006).
ChxR appears capable of dimerizing and binding DNA in the
absence of phosphorylation, consistent with the absence of both
the conserved aspartate and a cognate HK (Hickey et al., 2011).
Similar to CtcB/CtcC, a defined role for ChxR in chlamydial
physiology is lacking.
CHLAMYDIAL PROTEINS
PHOSPHORYLATED BY HOST KINASES
Chlamydia can deliver proteins into both the inclusion lumen
and host cytoplasm using the T3SS and a type 2 secretion
system (Hsia et al., 1997; Nguyen and Valdivia, 2012). At
least four of these proteins, translocated actin-recruiting protein
(TarP), translocated early phosphoprotein (TepP), and inclusion
membrane proteins A and G (IncA/IncG), are known to
be phosphorylated by host kinases (Rockey et al., 1997;
Scidmore and Hackstadt, 2001; Clifton et al., 2005; Chen
et al., 2014). While phosphorylation of TarP and TepP likely
play roles in chlamydial entry and inclusion formation, it is
less clear what role phosphorylation plays in the functions
of IncA/IncG. Of note, sequence diversity for both TarP,
including absence of the tyrosine phosphorylation motif in non-
C. trachomatis species, and IncA indicate that phosphorylation
of the homologs may not occur in all chlamydial species
(Bannantine et al., 1998; Delevoye et al., 2004; Clifton et al.,
2005). Two recent studies mapping the Inc protein interactome
and the inclusion proteome identified multiple host kinases
and phosphatases in association with the inclusion proteins or
inclusion making it highly likely that other chlamydial proteins
are reversibly phosphorylated by host enzymes (Aeberhard
et al., 2015; Mirrashidi et al., 2015). How phosphorylation of
these proteins contributes to the dynamic interplay between
the bacterium and host will be an exciting topic for future
research.
CONCLUDING REMARKS
Protein phosphorylation is a widely employed post-translational
modification that mediates important processes in bacteria
including cell signaling, enzyme activity, and protein-protein
interactions contributing to bacterial growth and virulence.
Chlamydia and other obligate intracellular bacterial pathogens
appear to encode a limited number of two-component signaling
systems compared to most free-living bacteria (Table 1),
which may reflect their restricted environmental niche. In
addition, only Chlamydia and Coxiella seem capable of
Ser/Thr/Tyr protein phosphorylation, and Chlamydia is
the lone species possessing a PSM. While limited in scope,
the maintenance of these phosphorylation pathways by
minimal genome organisms suggests that they are vital
for bacterial survival and pathogenesis, and chlamydial
mutagenesis and inhibitor studies are supportive of an
integral role for phosphorylation in development and
growth.
More research is needed to elucidate the physiological
role of protein phosphorylation in Chlamydia and other
obligate intracellular pathogens. Despite the validation of
chlamydial protein kinases, phosphatases, TCSSs, and the
sole PSM, their roles in vivo remain unclear. In addition, the
Ser/Thr/Tyr phosphoprotein network and an understanding
of the functional consequences of substrate phosphorylation
are far from complete. Fortunately, the burgeoning number
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of genetic methods now available for use with Chlamydia
(Bastidas and Valdivia, 2016) along with rapidly improving
methods for studying phosphoproteomes and transcriptomes
should empower researchers to address these significant
gaps in our knowledge of chlamydial physiology and
pathogenesis.
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